黑料官网

header-logo
GettyImages-145652391-hero
headshot

Y. David Seo, MD

Assistant Professor

view provider profile

Locations

  • Froedtert Hospital
  • Clinical Cancer Center - Froedtert Hospital

Specialties

  • Surgical Oncology
  • Hepatobiliary Surgery

Languages

  • English, Korean

Clinical Cancer Center - Froedtert Hospital

Education

  • MD - Doctor of Medicine

Biography

Publications

  • (Kamgar M, Hobbes GA, Davidson R, Dorbin D, Herrera J, Langenheim JF, Burge RA, Aldakkak M, Conrardy RD, Szabo A, Thalji SZ, Mayer B, Grahl JJ, Chung BY, Phan A, Thomas JP, Seo YD, Evans DB, Christians KK, Erickson B, Hall WA, George B, Tsai S, Lytle NK, Der CJ, Kurzrock R, McFall T.) Cancer Res. 2026 Apr 15;86(8):2042-2059 PMID: 41134578 PMCID: PMC13080315 SCOPUS ID: 2-s2.0-105031984871 10/24/2025

  • (Ayabe RI, Seo YD, Melendez B, Fields BC, Diggs LP, Lazcano R, Singh BB, Wani K, Ingram D, Johnson S, Chelvanambi M, Hudgens C, Hernandez SD, Ajami NJ, Wargo JA, Lazar AJ, Knafl M, Woodman S, Halperin DM, Estrella JS, Maxwell JE.) JCO Precis Oncol. 2025 Jul;9:e2500107 PMID: 40638874 PMCID: PMC12463141 07/10/2025

  • (Seo YD, Katz MHG, Snyder RA.) Ann Surg Oncol. 2025 Apr;32(4):2777-2785 PMID: 39815074 SCOPUS ID: 2-s2.0-85217156020 01/16/2025

  • (Seo YD, Acidi B, Newton A, Haddad A, Chiang YJ, Coelho R, Newhook TE, Tzeng CD, Chun YS, Ludmir EB, Koay EJ, Javle M, Vauthey JN, Cao HST.) Cancers (Basel). 2025 Feb 02;17(3) PMID: 39941861 PMCID: PMC11815919 02/13/2025

  • (Seo YD, Acidi B, Newton A, Haddad A, Chiang YJ, Coelho R, Newhook TE, Tzeng CWD, Chun YS, Ludmir EB, Koay EJ, Javle M, Vauthey JN, Cao HST.) Cancers. February 2025;17(3) SCOPUS ID: 2-s2.0-85217538724 02/01/2025

  • (Bhutiani N, Seo YD, Robinson KA, White MG, Ikoma N, Mansfield PF, Li JJ, Murphy MB, Ajani JA, Badgwell BD.) European Journal of Surgical Oncology. January 2025;51(1) SCOPUS ID: 2-s2.0-85207889387 01/01/2025

  • (Bhutiani N, Seo YD, Robinson KA, White MG, Ikoma N, Mansfield PF, Li JJ, Murphy MB, Ajani JA, Badgwell BD.) Eur J Surg Oncol. 2025 Jan;51(1):108790 PMID: 39489042 PMCID: PMC12622865 SCOPUS ID: 2-s2.0-85207889387 11/04/2024

  • (Fields BC, Ayabe RI, Seo YD, Maxwell JE, Halperin DM.) Curr Oncol Rep. 2024 Nov;26(11):1530-1542 PMID: 39466478 PMCID: PMC11776107 SCOPUS ID: 2-s2.0-85207815177 10/28/2024

  • (Glitza IC, Seo YD, Spencer CN, Wortman JR, Burton EM, Alayli FA, Loo CP, Gautam S, Damania A, Densmore J, Fairchild J, Cabanski CR, Wong MC, Peterson CB, Weiner B, Hicks N, Aunins J, McChalicher C, Walsh E, Tetzlaff MT, Hamid O, Ott PA, Boland GM, Sullivan RJ, Grossmann KF, Ajami NJ, LaVallee T, Henn MR, Tawbi HA, Wargo JA.) Cancer Discov. 2024 Jul 01;14(7):1161-1175 PMID: 38588588 PMCID: PMC11215408 SCOPUS ID: 2-s2.0-85197893321 04/08/2024

  • (Seo YD, Pollack SM.) JAMA Oncol. 2024 Jun 01;10(6):830-831 PMID: 38602667 SCOPUS ID: 2-s2.0-85190480277 04/11/2024

  • (Pothuri VS, Hogg GD, Conant L, Borcherding N, James CA, Mudd J, Williams G, Seo YD, Hawkins WG, Pillarisetty VG, DeNardo DG, Fields RC.) Oncoimmunology. 2024;13(1):2320411 PMID: 38504847 PMCID: PMC10950267 SCOPUS ID: 2-s2.0-85188105419 03/20/2024

  • (Ayabe RI, Seo YD, Melendez B, Segura RL, Fields BC, Wani KM, Johnson S, Witt R, Chelvanambi M, Hudgens C, Hernandez SD, Ajami NJ, Wargo JA, Lazar AJ, Halperin DM, Estrella J, Maxwell J.) Journal of Clinical Oncology. 2024;42(3) SCOPUS ID: 2-s2.0-105023311303 01/01/2024

Publications of from the

© 2026 黑料官网.  All rights reserved.  | Terms and Privacy | Web Accessibility Statement

Non-Discrimination, Anti-Harassment, and Legal Compliance Statement
The 黑料官网 (黑料官网) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, military status, or other legally protected classification. 黑料官网 maintains full compliance with all applicable federal, state, and local laws and regulations in pursuit of our missions. Consistent with federal guidance, we affirm our commitment to individual merit, fairness, and equal treatment in all aspects of academic and institutional decision-making.

黑料官网's policies, federal and state laws, and regulations prohibit unlawful discrimination and harassment. Employees, learners, students, applicants, or other members of the 黑料官网 community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic.